Cargando…

Non-Apoptotic Programmed Cell Death-Related Gene Signature Correlates With Stemness and Immune Status and Predicts the Responsiveness of Transarterial Chemoembolization in Hepatocellular Carcinoma

Background: Non-apoptotic programmed cell death, including autophagy, ferroptosis, and pyroptosis, newly discovered in recent years, plays an important role in hepatocellular carcinoma (HCC). So, this study attempted to explore the relationship between non-apoptotic programmed cell death-related gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guixiong, Fan, Wenzhe, Wang, Hongyu, Wen, Jie, Tan, Jizhou, Xue, Miao, Li, Jiaping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099410/ https://www.ncbi.nlm.nih.gov/pubmed/35573678 http://dx.doi.org/10.3389/fcell.2022.844013

Ejemplares similares

Integrative Functional Genomics Implicated the Key T-/B-Cell Deficiency Regulator RAG1 in Transarterial Chemoembolization of Hepatocellular Carcinoma
por: Xu, Yeyang, et al.
Publicado: (2021)

High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Li, Qiang, et al.
Publicado: (2021)

A 10-Gene Signature Identified by Machine Learning for Predicting the Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
por: Tang, Yiyang, et al.
Publicado: (2022)

Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Wang, Hongyu, et al.
Publicado: (2020)

Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma
por: Zhang, Xiaokai, et al.
Publicado: (2022)

Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma
por: Zhang, Guixiong, et al.
Publicado: (2022)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
por: Yao, Wang, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Survival and Metastasis for Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization
por: Fan, Wenzhe, et al.
Publicado: (2015)

Editorial: Non-apoptotic cell death mechanisms and their therapeutic significance
por: Lopus, Manu, et al.
Publicado: (2022)

Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
por: Xue, Miao, et al.
Publicado: (2020)

Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization
por: Fako, Valerie, et al.
Publicado: (2019)

Extracellular Vesicles Derived From Apoptotic Cells: An Essential Link Between Death and Regeneration
por: Li, Maojiao, et al.
Publicado: (2020)

KPT6566 induces apoptotic cell death and suppresses the tumorigenicity of testicular germ cell tumors
por: Sun, Ruijing, et al.
Publicado: (2023)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Non-Apoptotic Role of Apoptotic Caspases in the Drosophila Nervous System
por: Colon-Plaza, Sarah, et al.
Publicado: (2022)

Comparison of two transarterial chemoembolization regimens in patients with unresectable hepatocellular carcinoma: raltitrexed plus oxaliplatin versus 5-fluorouracil plus oxaliplatin
por: Cui, Wei, et al.
Publicado: (2017)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

A Novel Ten-Gene Signature Predicting Prognosis in Hepatocellular Carcinoma
por: Zhou, Taicheng, et al.
Publicado: (2020)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

Construction of a novel exosomes-related gene signature in hepatocellular carcinoma
por: Tao, Qiqi, et al.
Publicado: (2022)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

Involvement of the Actin Machinery in Programmed Cell Death
por: Ren, Weida, et al.
Publicado: (2021)

Glycometabolism-related gene signature of hepatocellular carcinoma predicts prognosis and guides immunotherapy
por: Yu, Lihua, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Adel, Hatem, et al.
Publicado: (2023)

Impact of Extracellular pH on Apoptotic and Non-Apoptotic TRAIL-Induced Signaling in Pancreatic Ductal Adenocarcinoma Cells
por: Hagelund, Sofie, et al.
Publicado: (2022)

Endogenous TRAIL-R4 critically impacts apoptotic and non-apoptotic TRAIL-induced signaling in cancer cells
por: Rambow, Anna-Christina, et al.
Publicado: (2022)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Liu, Shuang, et al.
Publicado: (2021)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
por: Shao, Ruo-Nan, et al.
Publicado: (2023)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
por: Chen, Shuling, et al.
Publicado: (2019)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
por: Liu, Han-jie, et al.
Publicado: (2020)

Cell Death Induction and Protection by Activation of Ubiquitously Expressed Anion/Cation Channels. Part 1: Roles of VSOR/VRAC in Cell Volume Regulation, Release of Double-Edged Signals and Apoptotic/Necrotic Cell Death
por: Okada, Yasunobu, et al.
Publicado: (2021)

m(6)A: An Emerging Role in Programmed Cell Death
por: Tang, Fajuan, et al.
Publicado: (2022)

The Function, Regulation and Mechanism of Programmed Cell Death of Macrophages in Atherosclerosis
por: Liu, Chang, et al.
Publicado: (2022)

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease
por: Zhou, Liuhua, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ndptii1vbg90pqngq1ttqge0qr